Atlas Trials

Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients

Clinical trial NCT00642928 · COMPLETED

Trial details

NCT number
NCT00642928
Sponsor
Bioprojet
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Excessive Daytime SleepinessParkinson's Disease
Start date
2007-10-01
Primary completion
2009-03-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.